Otsuka Pharmaceutical Development & Commercialization Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Respiratory Tract Diseases
Decision date
19/09/2025
Enrollment target
32
Sites
Bulgaria
Condition studied
Tuberculosis
Eligibility
Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.